A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
T
Teresa Batteiger, MD
Primary Investigator
Overview
Did you know? Gonorrhea can cause serious health problems if left untreated.
Gonorrhea is an infection caused by bacteria spread by sexual contact. Symptoms of gonorrhea include:
- Green, yellow or white discharge from the penis or vagina
- A burning feeling when urinating or in the throat
- Pain in the pelvis or testicles
But some people with gonorrhea - especially women - don't have any symptoms and don't know that they have an infection. That's why it's important to get yourself tested and/or treated if you think you have gonorrhea or have a partner with gonorrhea.
Researchers at Indiana University School of Medicine are looking for adults (ages 18 and up) to participate in a study on an investigational medication for gonorrhea.
Health insurance and/or doctor referrals are NOT required in order to participate.
Description
What Is This Study About?
Doctors and researchers are studying an investigational medication to better understand how it may cure gonorrhea infections.
Who is Eligible?
- Adults age 18 or older
- Have a suspected gonorrhea infection
What is Involved?
- Attend 3 study visits over the course of 21 days
- Visits are scheduled at a time that is convenient for you
- Participants who qualify will receive study-related care and medication from a local doctor at no cost
Participants will also receive reimbursement for travel to study visits/appointments
For more information, call Lora at 317-274-8453
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
adult,adults,gonorrhea,urogential gonorrhea
-
Age: Between 18 Years - 100 Years
-
Gender: All
You May Be Eligible for This Study If You:
- Are at least 18 years of age or older
- Have a suspected gonorrhea infection
*Doctors will also check other requirements to confirm that you qualify for this study
Updated on
26 Sep 2023.
Study ID: 1906646162